| Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange H Abboud, A Petrak, M Mealy, S Sasidharan, L Siddique, M Levy Multiple Sclerosis Journal 22 (2), 185-192, 2016 | 68 | 2016 |
| Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson's disease H Abboud, D Floden, NR Thompson, G Genc, S Oravivattanakul, ... Parkinsonism & related disorders 21 (3), 249-253, 2015 | 27 | 2015 |
| Essential tremor: choosing the right management plan for your patient H Abboud, A Ahmed, HH Fernandez Cleve Clin J Med 78 (12), 821-8, 2011 | 25 | 2011 |
| Comprehensive, multidisciplinary deep brain stimulation screening for Parkinson patients: no room for “short cuts” H Abboud, R Mehanna, A Machado, A Ahmed, M Gostkowski, S Cooper, ... Movement disorders clinical practice 1 (4), 336-341, 2014 | 17 | 2014 |
| Return of bradykinesia after subthalamic stimulation ceases: relationship to electrode location SE Cooper, AM Noecker, H Abboud, JL Vitek, CC McIntyre Experimental neurology 231 (2), 207-213, 2011 | 17 | 2011 |
| Neuromodulation in multiple sclerosis H Abboud, E Hill, J Siddiqui, A Serra, B Walter Multiple Sclerosis Journal 23 (13), 1663-1676, 2017 | 9 | 2017 |
| Socioeconomic Status M ay Impact Functional Outcome of Deep Brain Stimulation Surgery in P arkinson's Disease G Genc, H Abboud, S Oravivattanakul, F Alsallom, NR Thompson, ... Neuromodulation: Technology at the Neural Interface 19 (1), 25-30, 2016 | 8 | 2016 |
| Unusual case of levodopa-responsive camptocormia in a patient with negative dopamine transporter scan and normal DYT 5 gene S Oravivattanakul, H Abboud, H Fernandez, I Itin Clinical neuropharmacology 37 (2), 63-64, 2014 | 7 | 2014 |
| Predictors of functional and quality of life outcomes following deep brain stimulation surgery in Parkinson’s disease patients: disease, patient, and surgical factors H Abboud, G Genc, NR Thompson, S Oravivattanakul, F Alsallom, ... Parkinson’s Disease 2017, 2017 | 6 | 2017 |
| Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results H Abboud, I Rossman, MA Mealy, E Hill, N Thompson, A Banerjee, ... Journal of neurology 264 (11), 2284-2292, 2017 | 5 | 2017 |
| Camptocormia and Pisa syndrome as manifestations of acute myasthenia gravis exacerbation H Abboud, I Sivaraman, D Ontaneda, J Tavee Journal of the neurological sciences 359 (1), 8-10, 2015 | 5 | 2015 |
| Spinal Movement Disorders in Neuromyelitis Optica: An Under‐recognized Phenomenon H Abboud, HH Fernandez, MA Mealy, M Levy Movement Disorders Clinical Practice 3 (6), 596-602, 2016 | 2 | 2016 |
| Teaching NeuroImages: Manganese neurotoxicity of the basal ganglia and thalamus SE Lakhan, H Abboud Neurology 81 (14), e111-e111, 2013 | 1 | 2013 |
| Study of the association between the human leukocyte antigen class i molecules and remitting relapsing multiple sclerosis ms MA Ramadan, IR Ali, DH Mohamed, H Abboud, W El Gendy Bull. Alex. Fac. Med 44 (4), 2008 | 1 | 2008 |
| Iatrogenic CNS demyelination in the era of modern biologics N Kumar, H Abboud Multiple Sclerosis Journal, 1352458519828601, 2019 | | 2019 |
| Prevalence of asthma in multiple sclerosis: a United States population-based study E Hill, H Abboud, FBS Briggs Multiple sclerosis and related disorders 28, 69-74, 2019 | | 2019 |
| Movement disorders in early MS and related diseases: A prospective observational study H Abboud, XX Yu, K Knusel, HH Fernandez, JA Cohen Neurology: Clinical Practice 9 (1), 24-31, 2019 | | 2019 |
| Movement disorders in primary progressive MS: a prospective observational study H Abboud, S Woodson, A Serra MULTIPLE SCLEROSIS JOURNAL 24, 152-152, 2018 | | 2018 |
| Reversible Complete Blindness due to Bilateral Status Epilepticus Amauroticus Secondary to Hyperglycemia (P1. 288) D Chuang, F Alsallom, P Chompoopong, T Dickey, F Wang, N Pyatka, ... Neurology 90 (15 Supplement), P1. 288, 2018 | | 2018 |
| Spasticity-related Involuntary Movements: A Cross-sectional Study (P6. 052) H Abboud, H Fernandez, XX Yu, F Bethoux Neurology 90 (15 Supplement), P6. 052, 2018 | | 2018 |